About the Company
We do not have any company description for Liminatus Pharma, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Liminatus Pharma, Inc.
Liminatus Pharma Inc. Evaluates Formation of Digital Asset ... - WWLP
LA PALMA, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma Updates on CD47 Inhibitor IBA101
Liminatus Pharma ( ($LIMN) ) has provided an announcement. On August 14, 2025, Liminatus Pharma announced an update on its CD47 checkpoint ...
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary ...
LA PALMA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain ...
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment ...
LA PALMA, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Similar Companies
Loading the latest forecasts...